Skip to main content
OpenTrials

Clinical trial condition

Hairy Cell Leukemia

Explore clinical trials studying Hairy Cell Leukemia. Study availability and eligibility vary by location and protocol.

26 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Hairy Cell Leukemia trial results

Recruiting

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

NCT06561360

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

NCT06965114

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Therapy Optimisation for the Treatment of Hairy Cell Leukemia

NCT02131753

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Community based hemato-oncology medical office Ansbach, Germany
  • Community based hemato-oncology medical office Aschaffenburg, Germany
  • Rhön-Saale-Klinik gGmbH Bad Neustadt an der Saale, Germany
  • Community based hemato-oncology medical office Berlin, Germany
View all 76 locations
View Trial Details

Related conditions